# A Bioequivalence Study of L04TD2 Compared to Administration of L04RD1 in Healthy Volunteers

> **NCT05581693** · PHASE1 · COMPLETED · sponsor: **Celltrion** · enrollment: 50 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** L04RD1
- **DRUG:** L04TD2
- **DRUG:** L04TD2
- **DRUG:** L04RD1

## Key facts

- **NCT ID:** NCT05581693
- **Lead sponsor:** Celltrion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-30
- **Primary completion:** 2022-11-01
- **Final completion:** 2022-11-29
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05581693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05581693, "A Bioequivalence Study of L04TD2 Compared to Administration of L04RD1 in Healthy Volunteers". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05581693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*